Viking Fund Management LLC Invests $107,000 in Sanofi (NASDAQ:SNY)

Viking Fund Management LLC acquired a new stake in Sanofi (NASDAQ:SNY) in the first quarter, according to the company in its most recent filing with the SEC. The firm acquired 2,200 shares of the company’s stock, valued at approximately $107,000.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Rise Advisors LLC increased its position in shares of Sanofi by 98.4% during the fourth quarter. Rise Advisors LLC now owns 506 shares of the company’s stock valued at $25,000 after buying an additional 251 shares during the period. Salem Investment Counselors Inc. bought a new position in Sanofi in the 4th quarter worth about $27,000. Venturi Wealth Management LLC raised its holdings in shares of Sanofi by 163.5% in the 4th quarter. Venturi Wealth Management LLC now owns 535 shares of the company’s stock valued at $27,000 after acquiring an additional 332 shares in the last quarter. Frazier Financial Advisors LLC purchased a new position in shares of Sanofi during the fourth quarter worth about $28,000. Finally, McIlrath & Eck LLC grew its holdings in shares of Sanofi by 143.3% during the fourth quarter. McIlrath & Eck LLC now owns 613 shares of the company’s stock worth $30,000 after purchasing an additional 361 shares in the last quarter. Institutional investors and hedge funds own 10.04% of the company’s stock.

Sanofi Trading Down 0.5 %

SNY stock traded down $0.25 during midday trading on Thursday, hitting $48.08. The company had a trading volume of 1,061,360 shares, compared to its average volume of 2,104,007. The company has a current ratio of 1.27, a quick ratio of 0.87 and a debt-to-equity ratio of 0.19. Sanofi has a 52 week low of $42.63 and a 52 week high of $55.72. The stock has a market cap of $121.77 billion, a price-to-earnings ratio of 24.29, a PEG ratio of 1.55 and a beta of 0.60. The stock’s 50 day moving average price is $48.53 and its 200 day moving average price is $48.55.

Sanofi (NASDAQ:SNY) last released its quarterly earnings data on Thursday, April 25th. The company reported $0.96 earnings per share for the quarter, hitting the consensus estimate of $0.96. Sanofi had a return on equity of 26.25% and a net margin of 10.52%. The business had revenue of $11.36 billion during the quarter, compared to analysts’ expectations of $11.75 billion. As a group, equities research analysts expect that Sanofi will post 4.13 earnings per share for the current fiscal year.

Sanofi Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.